Bolstered by the Allergan neuroscience legacy, AbbVie is a committed leader in migraine with an almost 25-year history in migraine research. Our current migraine treatments demonstrate our dedication to addressing the unmet needs of migraine patients – and we continue to strive for science that makes a difference.